Evidence supporting the use of: Ferulic acid derivative
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Ferulic acid and its derivatives have attracted scientific interest for their potential role in supporting or treating diabetic retinopathy (DR), largely due to their antioxidant and anti-inflammatory properties. Preclinical studies, particularly in animal models and in vitro experiments, have suggested that ferulic acid can reduce oxidative stress, inhibit retinal cell apoptosis, and decrease inflammatory cytokines—all mechanisms implicated in the pathogenesis of DR. For example, some studies in diabetic rats have shown that ferulic acid administration can reduce retinal vascular leakage, prevent capillary degeneration, and suppress the expression of vascular endothelial growth factor (VEGF), a key driver of retinal neovascularization. However, evidence from clinical trials in humans is scarce. There are currently no large, well-controlled studies demonstrating the efficacy of ferulic acid derivatives in preventing or treating diabetic retinopathy in patients. The existing research is mostly preclinical, and while the results are promising, they are not sufficient to warrant strong clinical recommendations. Therefore, while the use of ferulic acid derivatives for DR is scientifically plausible and supported by basic research, the overall evidence is limited (rated 2 out of 5) and mainly consists of laboratory and animal data rather than robust clinical validation.

More about Ferulic acid derivative
More about Diabetic Retinopathy

Products containing Ferulic acid derivative

We currently have no products on Vitabase that contain this ingredient.